OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia
Changya Chen, Wenbao Yu, Fatemeh Alikarami‬, et al.
Blood (2021) Vol. 139, Iss. 14, pp. 2198-2211
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging
Shovik Bandyopadhyay, Michael P. Duffy, Kyung Jin Ahn, et al.
Cell (2024) Vol. 187, Iss. 12, pp. 3120-3140.e29
Open Access | Times Cited: 54

Clinical and translational relevance of intratumor heterogeneity
Marie-Anne Goyette, Marla Lipsyc-Sharf, Kornélia Polyák
Trends in cancer (2023) Vol. 9, Iss. 9, pp. 726-737
Open Access | Times Cited: 23

A longitudinal single-cell atlas of treatment response in pediatric AML
Sander Lambo, Diane L. Trinh, Rhonda E. Ries, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2117-2135.e12
Open Access | Times Cited: 22

The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies
Jadwiga Filipek-Gorzała, Patrycja Kwiecińska, Agata Szade, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9

Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia
Xin Huang, Yizhen Li, Jingliao Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 552-567.e6
Open Access | Times Cited: 9

An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup
Mark Gower, Ximing Li, Alicia G. Aguilar-Navarro, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 779
Closed Access | Times Cited: 1

The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age
Thomas Beder, Björn-Thore Hansen, Alina M. Hartmann, et al.
HemaSphere (2023) Vol. 7, Iss. 9, pp. e939-e939
Open Access | Times Cited: 21

The use of single-cell multi-omics in immuno-oncology
Anjun Ma, Gang Xin, Qin Ma
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27

Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
Laurence C. Cheung, Carlos Aya‐Bonilla, Mark N. Cruickshank, et al.
Leukemia (2022) Vol. 37, Iss. 1, pp. 61-71
Open Access | Times Cited: 27

Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
Eline J.M. Bertrums, Axel Rosendahl Huber, Jurrian K. de Kanter, et al.
Cancer Discovery (2022), pp. OF1-OF14
Open Access | Times Cited: 23

Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
Rathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Blood (2023) Vol. 142, Iss. 21, pp. 1806-1817
Open Access | Times Cited: 14

Role of epigenetics in paediatric cancer pathogenesis & drug resistance
Jia Yu Leung, Hsin Yao Chiu, Reshma Taneja
British Journal of Cancer (2025)
Closed Access

Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights
Ilaria Iacobucci, Matthew T. Witkowski, Charles G. Mullighan
Blood (2022) Vol. 141, Iss. 4, pp. 356-368
Open Access | Times Cited: 19

Scalable single-cell profiling of chromatin modifications with sciCUT&Tag
Derek H. Janssens, Jacob E. Greene, Steven J. Wu, et al.
Nature Protocols (2023) Vol. 19, Iss. 1, pp. 83-112
Open Access | Times Cited: 11

A shadow in the treatment of acute leukemia: lineage switch
Qi Zhou, Ying Wang
Blood Science (2025) Vol. 7, Iss. 2, pp. e00220-e00220
Open Access

To B‐ or not to B‐: A review of lineage switched acute leukemia
Jason H. Kurzer, Olga K. Weinberg
International Journal of Laboratory Hematology (2022) Vol. 44, Iss. S1, pp. 64-70
Open Access | Times Cited: 16

Concepts in B cell acute lymphoblastic leukemia pathogenesis
Clarissa Garcia, Megan D Miller-Awe, Matthew T. Witkowski
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 1, pp. 18-32
Closed Access | Times Cited: 3

Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance
Huihui Fan, Feng Wang, Andy G.X. Zeng, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8

A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma
Jonathan H. Sussman, Derek A. Oldridge, Wenbao Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Aberrant stem cell and developmental programs in pediatric leukemia
Rebecca E. Ling, Joe W. Cross, Anindita Roy
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

MLL oncoprotein levels influence leukemia lineage identities
Derek H. Janssens, M. Durán, Dominik J. Otto, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top